Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data

被引:0
|
作者
Martinelli, Francesca [1 ]
Quinten, Chantal [1 ]
Maringwa, John T. [1 ]
Coens, Corneel [1 ]
Vercauteren, Jurgen [1 ,2 ]
Cleeland, Charles S. [3 ]
Flechtner, Henning [4 ]
Gotay, Carolyn [5 ]
Greimel, Eva [6 ]
King, Madeleine [7 ]
Mendoza, Tito [3 ]
Osoba, David [8 ]
Reeve, Bryce B. [9 ]
Ringash, Jolie [10 ]
Schmucker-Von Koch, Joseph [11 ]
Shi, Qiuling [3 ]
Taphoorn, Martin J. [12 ,13 ]
Weis, Joachim [14 ]
Bottomley, Andrew [1 ]
机构
[1] European Org Res Treatment Canc, Qual Life Dept, Brussels, Belgium
[2] Katholieke Univ Leuven, Rega Inst, Louvain, Belgium
[3] Univ Texas Houston, MD Anderson Canc Ctr, Dept Symptom Res, Houston, TX 77030 USA
[4] Clin Child & Adolescent Psychiat & Psychotherapy, Magdeburg, Germany
[5] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada
[6] Graz Univ, Dept Obstet & Gynecol, Graz, Austria
[7] Univ Sydney, Psychooncol Cooperat Res Grp, Sydney, NSW 2006, Australia
[8] Qual Life Consulting, W Vancouver, BC, Canada
[9] NCI, Bethesda, MD 20892 USA
[10] Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada
[11] Univ Regensburg, Med Eth Philosoph Fac, Regensburg, Germany
[12] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[13] Med Ctr Haaglanden, The Hague, Netherlands
[14] Univ Freiburg, Dept Psychooncol, Freiburg, Germany
关键词
cancer; clinical trials; cluster analysis; patient-reported outcomes; quality of life; PHASE-III TRIAL; METASTATIC BREAST-CANCER; CELL LUNG-CANCER; EUROPEAN-ORGANIZATION; PROSTATE-CANCER; SYMPTOM CLUSTERS; COLORECTAL-CANCER; ADJUVANT THERAPY; RANDOMIZED-TRIAL; CHEMOTHERAPY;
D O I
10.1586/ERP.11.51
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Aims: Cancer patients experience multiple and concurrent health-related problems and symptoms due to their illness and therapies. The first objective of this analysis was to identify how health-related quality-of-life (HRQoL) indicators cluster among cancer patients and how possible clusters change across patients with different sociodemographic and clinical characteristics. The second objective of this study was to identify which HRQoL indicators are linked to patients' perception of overall quality of life. Methods: Retrospective pooling of 30 closed randomized European Organisation for Research and Treatment of Cancer (EORTC) clinical trials yielded baseline EORTC Quality of Life Core Questionnaire (QLQ-C30) HRQoL data for a total of 7417 patients. A cluster analysis was performed to determine how the 15 HRQoL indicators obtained with the QLQ-C30 cluster overall and by patient characteristics. Results: Three main clusters emerged from the overall dataset: a physical cluster, a psychological cluster and a gastrointestinal cluster. The same clusters were found in subgroups defined according to sociodemographic and clinical characteristics, while some differences emerged among cancer sites. The Global Health scale was found to be part of the physical cluster in the overall dataset. This result was consistent across different levels of disease severity, while divergent results were seen across some cancer sites. Conclusion: Our findings suggest that HRQoL indicators are interrelated. Understanding these relationships may aid clinicians in managing the symptom burden experienced by patients, as well as policy-makers, in defining psychosocial support plans.
引用
收藏
页码:587 / 599
页数:13
相关论文
共 50 条
  • [21] Health-related quality of life in Croatian general population and multiple myeloma patients assessed by the EORTC QLQ-C30 and EORTC QLQ-MY20 questionnaires
    Ficko, Sanja Ledinski
    Pejsa, Vlatko
    Zadnik, Vesna
    RADIOLOGY AND ONCOLOGY, 2019, 53 (03) : 337 - 347
  • [22] Reliability and validity of Amharic version of EORTC QLQ-C30 and QLQ-BR23 modules for assessing health-related quality of life among breast cancer patients in Ethiopia
    Diriba Alemayehu Gadisa
    Esayas Tadesse Gebremariam
    Getnet Yimer Ali
    Health and Quality of Life Outcomes, 17
  • [23] Responsiveness of EORTC QLQ-C30, QLQ-CR38 and FACT-C quality of life questionnaires in patients with colorectal cancer
    Uwer, Lionel
    Rotonda, Christine
    Guillemin, Francis
    Miny, Joeelle
    Kaminsky, Marie-Christine
    Mercier, Mariette
    Tournier-Rangeard, Laetitia
    Leonard, Isabelle
    Montcuquet, Philippe
    Rauch, Philippe
    Conroy, Thierry
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2011, 9
  • [24] Reporting of health-related quality of life (HRQOL) data in oncology trials: a comparison of the European Organization for Research and Treatment of Cancer Quality of Life (EORTC QLQ-C30) and the Functional Assessment of Cancer Therapy-General (FACT-G)
    Smith, Adam B.
    Cocks, Kim
    Parry, David
    Taylor, Matthew
    QUALITY OF LIFE RESEARCH, 2014, 23 (03) : 971 - 976
  • [25] The EORTC Quality of Life Questionnaire for cancer patients (QLQ-C30): Australian general population reference values
    Mercieca-Bebber, Rebecca
    Costa, Daniel S. J.
    Norman, Richard
    Janda, Monika
    Smith, David P.
    Grimison, Peter
    Gamper, Eva-Marie
    King, Madeleine T.
    MEDICAL JOURNAL OF AUSTRALIA, 2019, 210 (11) : 499 - 506
  • [26] The relationship between global and specific components of quality of life, assessed with the EORTC QLQ-C30 in a sample of 2019 cancer patients
    Hinz, A.
    Mehnert, A.
    Degi, C.
    Reissmann, D. R.
    Schotte, D.
    Schulte, T.
    EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (02)
  • [27] Responsiveness of EORTC QLQ-C30, QLQ-CR38 and FACT-C quality of life questionnaires in patients with colorectal cancer
    Lionel Uwer
    Christine Rotonda
    Francis Guillemin
    Joëlle Miny
    Marie-Christine Kaminsky
    Mariette Mercier
    Laetitia Tournier-Rangeard
    Isabelle Leonard
    Philippe Montcuquet
    Philippe Rauch
    Thierry Conroy
    Health and Quality of Life Outcomes, 9
  • [28] General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States
    Nolte, S.
    Liegl, G.
    Petersen, M. A.
    Aaronson, N. K.
    Costantini, A.
    Fayers, P. M.
    Groenvold, M.
    Holzner, B.
    Johnson, C. D.
    Kemmler, G.
    Tomaszewski, K. A.
    Waldmann, A.
    Young, T. E.
    Rose, M.
    EUROPEAN JOURNAL OF CANCER, 2019, 107 : 153 - 163
  • [29] Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients
    Sneeuw, KCA
    Aaronson, NK
    Sprangers, MAG
    Detmar, SB
    Wever, LDV
    Schornagel, JH
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (07) : 617 - 631
  • [30] Predictive factors of overall quality of life in advanced cancer patients using EORTC QLQ-C30
    Cramarossa, Gemma
    Zeng, Liang
    Zhang, Liying
    Tseng, Ling-Ming
    Hou, Ming-Feng
    Fairchild, Alysa
    Vassiliou, Vassilios
    Jesus-Garcia, Reynaldo
    El-Din, Mohamed A. Alm
    Kumar, Aswin
    Forges, Fabien
    Chie, Wei-Chu
    Sahgal, Arjun
    Lam, Henry
    Pulenzas, Natalie
    Chow, Edward
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2014, 14 (01) : 139 - 146